Unnamed: 0,title,date,stock,sentiment
68388.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-29 07:39:00-04:00,AMAG,neutral
68389.0,"The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray",2020-05-22 07:10:00-04:00,AMAG,neutral
68390.0,"SunTrust Robinson Humphrey Maintains Hold on AMAG Pharmaceuticals, Raises Price Target to $7",2020-05-15 09:31:00-04:00,AMAG,neutral
68391.0,"JP Morgan Maintains Underweight on AMAG Pharmaceuticals, Lowers Price Target to $8",2020-05-12 11:00:00-04:00,AMAG,positive
68392.0,"HC Wainwright & Co. Reiterates Buy on AMAG Pharmaceuticals, Raises Price Target to $10",2020-05-12 07:05:00-04:00,AMAG,neutral
68393.0,"SVB Leerink Reiterates Market Perform on AMAG Pharmaceuticals, Lowers Price Target to $9",2020-05-12 06:25:00-04:00,AMAG,negative
68394.0,78 Biggest Movers From Yesterday,2020-05-12 05:02:00-04:00,AMAG,neutral
68395.0,54 Stocks Moving In Monday's Mid-Day Session,2020-05-11 12:39:00-04:00,AMAG,neutral
68396.0,AMAG Pharmaceuticals: Q1 Earnings Insights,2020-05-11 07:32:00-04:00,AMAG,neutral
68397.0,"AMAG Pharmaceuticals Q1 EPS $(0.720) Misses $(0.030) Estimate, Sales $68.661M Beat $64.820M Estimate",2020-05-11 07:17:00-04:00,AMAG,negative
68398.0,"AMAG Pharma Reports Pres, CEO William Heiden To Step Down; Names Scott Myers Replacement",2020-04-28 07:15:00-04:00,AMAG,neutral
68399.0,"H.C. Wainwright Maintains Buy on AMAG Pharmaceuticals, Lowers Price Target to $9",2020-04-17 07:17:00-04:00,AMAG,negative
68400.0,AMAG Pharmaceuticals Says At This Time Supply Chain Has Not Been Affected By Coronavirus,2020-04-16 08:07:00-04:00,AMAG,positive
68401.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,AMAG,negative
68402.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,AMAG,negative
68403.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,AMAG,negative
68404.0,AMAG Pharmaceuticals Sees FY20 Sales $230M-$280M vs $254.44M Est.,2020-03-04 07:14:00-05:00,AMAG,neutral
68405.0,"AMAG Pharmaceuticals Q4 EPS $(5.89) Does Not Compare To $(0.36) Estimate, Sales $89.7M Beat $88.39M Estimate",2020-03-04 07:13:00-05:00,AMAG,neutral
68406.0,AMAG Pharmaceuticals Announces Changes to Medical Development Organization,2020-03-04 06:59:00-05:00,AMAG,neutral
68407.0,"H.C. Wainwright Maintains Buy on AMAG Pharmaceuticals, Lowers Price Target to $12",2020-03-03 09:47:00-05:00,AMAG,negative
68408.0,43 Healthcare Stocks Moving In Tuesday's After-Market Session,2020-01-28 23:40:00-05:00,AMAG,neutral
68409.0,70 Biggest Movers From Friday,2020-01-27 04:02:00-05:00,AMAG,neutral
68410.0,44 Stocks Moving In Friday's Mid-Day Session,2020-01-24 12:08:00-05:00,AMAG,neutral
68411.0,UPDATE: AMAG Says FY20 Guidance 'reflects reduction in annual operating expenses of more than $100M and a return to positive adjusted EBITDA',2020-01-09 07:07:00-05:00,AMAG,positive
68412.0,AMAG Reports Has Initiated CEO Transition Plan,2020-01-09 07:06:00-05:00,AMAG,neutral
68413.0,"AMAG Pharma Reports Will Divest Intrarosa, Vyleesi",2020-01-09 07:06:00-05:00,AMAG,neutral
68414.0,12 Biotech Stocks Primed For A Short Squeeze,2019-12-06 08:00:00-05:00,AMAG,neutral
68415.0,"Barclays Maintains Overweight on AMAG Pharmaceuticals, Lowers Price Target to $14",2019-11-04 07:58:00-05:00,AMAG,negative
68416.0,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",2019-11-01 07:38:00-04:00,AMAG,neutral
68417.0,"AMAG Pharmaceuticals Q3 EPS $(0.7) Misses $(0.66) Estimate, Sales $84.131M Miss $88.18M Estimate",2019-11-01 07:10:00-04:00,AMAG,negative
68418.0,AMAG Pharmaceuticals shares are trading lower. Not seeing any news to justify the price action.,2019-10-31 11:21:00-04:00,AMAG,neutral
68419.0,28 Biggest Movers From Yesterday,2019-10-31 07:47:00-04:00,AMAG,neutral
68420.0,Mid-Afternoon Market Update: Energy Stocks Fall 2%; US Fed Cuts Interest Rates,2019-10-30 14:42:00-04:00,AMAG,positive
68421.0,"Mid-Day Market Update: Oil Falls As US Inventory Rises; Big 5 Sporting Goods Spikes On Q3 Beat, Higher Guidance",2019-10-30 12:19:00-04:00,AMAG,neutral
68422.0,28 Stocks Moving In Wednesday's Mid-Day Session,2019-10-30 12:10:00-04:00,AMAG,neutral
68423.0,"Benzinga's Top Upgrades, Downgrades For October 30, 2019",2019-10-30 10:34:00-04:00,AMAG,positive
68424.0,AMAG Pharmaceuticals Falls 25% After FDA Recommends Removing Makena From The Market,2019-10-30 09:20:00-04:00,AMAG,positive
68425.0,10 Biggest Price Target Changes For Wednesday,2019-10-30 08:26:00-04:00,AMAG,neutral
68426.0,Amag Pharmaceuticals Resumes Trading,2019-10-30 07:10:00-04:00,AMAG,neutral
68427.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,AMAG,negative
68428.0,"PiperJaffray Downgrades AMAG Pharmaceuticals to Underweight, Lowers Price Target to $6",2019-10-30 06:27:00-04:00,AMAG,negative
68429.0,AMAG Says Disappointed with FDA Advisory Committee Split Vote for Makena,2019-10-30 03:38:00-04:00,AMAG,negative
68430.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,AMAG,positive
68431.0,UPDATE: AMAG Says AdCom Panel Scheduled To Start At 8:15 a.m. EDT; Briefing Materials Available,2019-10-29 07:17:00-04:00,AMAG,neutral
68432.0,AMAG Pharmaceuticals Says FDA Will Hold Meeting To 'better understand and interpret' PROLONG Trial Data For Makena,2019-10-29 07:06:00-04:00,AMAG,positive
68433.0,"AMAG Pharmaceuticals Shares Halted, News Pending",2019-10-29 07:00:00-04:00,AMAG,positive
68434.0,AMAG Pharmaceuticals shares are trading higher in sympathy with the overall market from progression in U.S.-China trade talks and positive sentiment from strong earnings reports.,2019-10-28 14:31:00-04:00,AMAG,positive
68435.0,51 Biggest Movers From Friday,2019-10-28 05:27:00-04:00,AMAG,neutral
68436.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,AMAG,neutral
68437.0,AMAG Pharmaceuticals shares are trading higher on seemingly no company-specific news.,2019-10-25 10:04:00-04:00,AMAG,neutral
68438.0,AMAG Pharmaceuticals shares are trading lower on seemingly no company-specific news.,2019-10-24 14:15:00-04:00,AMAG,negative
68439.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,AMAG,neutral
68440.0,"Shares of several healthcare companies are trading lower, potentially on recent Democratic primary polls showing Senator Elizabeth Warren in the lead.",2019-09-26 12:43:00-04:00,AMAG,neutral
68441.0,Shares of many pharma/therapeutics stocks trading lower in sympathy with overall market weakness. Reports China is planning to cut prices for widely-used drugs may also be pressuring the sector today.,2019-09-24 14:01:00-04:00,AMAG,negative
68442.0,45 Biggest Movers From Friday,2019-09-23 06:08:00-04:00,AMAG,neutral
68443.0,36 Stocks Moving In Friday's Mid-Day Session,2019-09-20 12:23:00-04:00,AMAG,neutral
68444.0,AMAG Pharmaceuticals shares are trading higher after the company's 13D filing showed that Chamber Capital Management holds a 12.9% stake in the company.,2019-09-20 10:56:00-04:00,AMAG,positive
68445.0,AMAG Pharmaceuticals 13D Shows Camber Capital Management Holds 12.9% Stake In Co.,2019-09-20 08:06:00-04:00,AMAG,neutral
68446.0,"Activist Investor Caligan Is Reportedly Seeking To Replace Four Directors At AMAG Pharmaceuticals, Including Its Chairman",2019-09-04 07:18:00-04:00,AMAG,neutral
68447.0,AMAG Pharmaceuticals Announces Vyleesi Is Not Available Commercially,2019-08-27 08:08:00-04:00,AMAG,neutral
68448.0,Caligan Partners Says May Develop Plans Or Make Proposals Regarding Potential Strategic Review Or Sale Process Involving AMAG Pharmaceuticals Or Its Assets,2019-08-15 15:08:00-04:00,AMAG,positive
68449.0,Activist Investor Caligan Partners Has Built Stake In Amag Pharmaceuticals And Plans To Push For Changes At The Company,2019-08-15 14:11:00-04:00,AMAG,neutral
68450.0,AMAG Pharmaceuticals: Hearing Caligan Partners To Have Built 10% Stake In Co.,2019-08-15 14:02:00-04:00,AMAG,neutral
68451.0,ï»¿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,AMAG,positive
68452.0,"Jim Cramer Shares His Thoughts On Delta Air Lines, Okta And More",2019-08-13 11:42:00-04:00,AMAG,positive
68453.0,76 Biggest Movers From Yesterday,2019-08-13 04:57:00-04:00,AMAG,neutral
68454.0,AMAG Pharmaceuticals shares are trading higher on seemingly no company-specific news.,2019-08-12 15:04:00-04:00,AMAG,neutral
68455.0,90 Biggest Movers From Friday,2019-08-12 05:49:00-04:00,AMAG,neutral
68456.0,90 Biggest Movers From Yesterday,2019-08-08 05:17:00-04:00,AMAG,neutral
68457.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,AMAG,negative
68458.0,75 Stocks Moving In Wednesday's Mid-Day Session,2019-08-07 13:16:00-04:00,AMAG,neutral
68459.0,AMAG Pharmaceuticals shares are trading lower after the company reported weak Q2 earnings results.,2019-08-07 08:33:00-04:00,AMAG,negative
68460.0,"AMAG Pharmaceuticals Q2 EPS $(3.57) Does Not Compare To $(0.49) Estimate, Sales $78.109M Miss $92.02M Estimate",2019-08-07 08:20:00-04:00,AMAG,negative
68461.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,AMAG,neutral
68462.0,"Benzinga's Top Upgrades, Downgrades For August 1, 2019",2019-08-01 09:53:00-04:00,AMAG,positive
68463.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-01 09:38:00-04:00,AMAG,neutral
68464.0,"H.C. Wainwright Initiates Coverage On AMAG Pharmaceuticals with Buy Rating, Announces $16 Price Target",2019-08-01 07:27:00-04:00,AMAG,neutral
68465.0,"Amag Pharmaceuticals 10%+ Owner Steven Boyd Buys 498,016 @ Avg Price: $8.87",2019-06-27 18:41:00-04:00,AMAG,neutral
68466.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-06-25 08:04:00-04:00,AMAG,neutral
68467.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,AMAG,neutral
68468.0,34 Stocks Moving In Monday's Pre-Market Session,2019-06-24 08:04:00-04:00,AMAG,neutral
68469.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",2019-06-22 15:07:00-04:00,AMAG,neutral
68470.0,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",2019-06-21 07:18:00-04:00,AMAG,negative
68471.0,"Barclays Initiates Coverage On AMAG Pharmaceuticals with Overweight Rating, Announces $19 Price Target",2019-06-11 07:23:00-04:00,AMAG,negative
68472.0,"Jim Cramer Shares His Thoughts On AMD, CME Group, Microsoft And More",2019-06-05 07:26:00-04:00,AMAG,positive
68473.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,AMAG,positive
68474.0,"The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug",2019-05-30 07:33:00-04:00,AMAG,positive
68475.0,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",2019-05-21 07:40:00-04:00,AMAG,negative
68476.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,AMAG,negative
68477.0,72 Biggest Movers From Yesterday,2019-05-08 06:17:00-04:00,AMAG,neutral
68478.0,64 Stocks Moving In Tuesday's Mid-Day Session,2019-05-07 12:17:00-04:00,AMAG,neutral
68479.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,AMAG,neutral
68480.0,"AMAG Pharmaceuticals Q1 EPS $(3.54) Misses $(0.26) Estimate, Sales $75.8M Miss $90.11M Estimate",2019-05-07 07:14:00-04:00,AMAG,negative
68481.0,AMAG Pharma To Present New Data At American College of Obstetricians and Gynecologists Annual Meeting,2019-05-03 08:08:00-04:00,AMAG,neutral
68482.0,SunTrust Robinson Humphrey Initiates Coverage On AMAG Pharmaceuticals with Hold Rating,2019-03-20 07:26:00-04:00,AMAG,neutral
68483.0,70 Biggest Movers From Friday,2019-03-11 05:26:00-04:00,AMAG,neutral
68484.0,50 Stocks Moving In Friday's Mid-Day Session,2019-03-08 12:31:00-05:00,AMAG,neutral
68485.0,AMAG Pharmaceuticals shares are trading lower after the company reported topline results from its PROLONG trial did not demonstrate any statistically significant difference between the treatment and placebo arms for co-primary endpoints.,2019-03-08 11:30:00-05:00,AMAG,positive
68486.0,AMAG Pharma Reports Topline Results From PROLONG Trial Evaluating Makena: Did Not Demonstrate Statistically Significant Difference Between Treatment And Placebo Arms For Co-Primary Endpoints,2019-03-08 08:02:00-05:00,AMAG,negative
68487.0,"The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings",2019-03-08 07:38:00-05:00,AMAG,neutral
68488.0,AMAG Pharmaceuticals Highlights Presentation Of New Data On Bremelanotide And Hypoactive Sexual Desire Disorder At ISSWSH/ISSM Joint Meeting,2019-03-07 08:07:00-05:00,AMAG,neutral
68489.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,AMAG,negative
68490.0,AMAG Pharmaceuticals Sees FY19 Sales $365M-$415M vs $382.51M Est.,2019-02-07 08:38:00-05:00,AMAG,neutral
68491.0,"AMAG Pharmaceuticals Earlier Reported Q4 EPS $(0.60) Beats $(1.09) Estimate, Sales $88.122M Miss $98.92M Estimate",2019-02-07 08:37:00-05:00,AMAG,negative
68492.0,AMAG Pharmaceuticals Says FY19 Shipments Growth Too Early For Forecast,2019-01-10 11:03:00-05:00,AMAG,positive
68493.0,AMAG Pharmaceuticals Sees FY2018 Sales $471.0M-476.0M Which May Not Compare $490.94M Est,2019-01-07 07:22:00-05:00,AMAG,neutral
68494.0,AMAG Pharmaceuticals Sees Q4 Sales $85.0M-90.0M vs $101.90M Est,2019-01-07 07:21:00-05:00,AMAG,neutral
68495.0,AMAG Pharma Reports Deal To Buy Perosphere Pharma For $50M,2018-12-13 06:30:00-05:00,AMAG,neutral
68496.0,28 Stocks Moving In Tuesday's Pre-Market Session,2018-11-13 08:06:00-05:00,AMAG,neutral
68497.0,AMAG Pharmaceuticals Says FDA Has Requested Additional Data Be Generated From Small Phase 1 Study Of Vyleesi,2018-11-13 07:16:00-05:00,AMAG,neutral
68498.0,"JP Morgan Downgrades AMAG Pharmaceuticals to Underweight, Lowers Price Target to $18",2018-11-06 05:51:00-05:00,AMAG,positive
68499.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,AMAG,neutral
68500.0,56 Stocks Moving In Thursday's Mid-Day Session,2018-11-01 12:59:00-04:00,AMAG,neutral
68501.0,"AMAG Pharma Q3 Adj. EPS $(1.70) Misses $(0.79) Estimate, Sales $122.238M Beat $120.1M Estimate",2018-11-01 07:43:00-04:00,AMAG,negative
68502.0,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",2018-11-01 07:30:00-04:00,AMAG,negative
68503.0,"AMAG Pharmaceuticals Acquires Digoxin Immune Fab, An Orphan Drug Candidate For Treatment Of Severe Preeclampsia",2018-09-26 06:33:00-04:00,AMAG,positive
68504.0,"UPDATE: AMAG Will Also Pay $35M Milestone Payment Upon FDA Approval, Sales Milestone Payments Of Up To $240M",2018-09-26 06:31:00-04:00,AMAG,positive
68505.0,AMAG Pharma Reports Purchase Of Orphan Drug Candidate For Treatment Of Severe Preeclampsia For Upfront Fee Of $12.5M,2018-09-26 06:30:00-04:00,AMAG,negative
68506.0,AMAG Pharmaceuticals Pays Off $475M Of Senior Secured Notes,2018-09-06 08:04:00-04:00,AMAG,positive
68507.0,"AMAG Pharmaceuticals Q2 EPS $(0.75) Misses $(0.37) Estimate, Sales $146.3M Miss $155.81M Estimate",2018-08-02 07:10:00-04:00,AMAG,negative
68508.0,AMAG Announces Intention To Launch A Generic Version Of Single-Dose Makena,2018-06-25 08:13:00-04:00,AMAG,neutral
68509.0,"B. Riley FBR Upgrades AMAG Pharmaceuticals to Buy, Raises Price Target to $30",2018-06-15 14:09:00-04:00,AMAG,neutral
68510.0,Hearing B. Riley Upgraded Amag Pharmaceutical To Buy,2018-06-15 13:46:00-04:00,AMAG,neutral
68511.0,30 Stocks Moving In Friday's Mid-Day Session,2018-06-15 12:23:00-04:00,AMAG,neutral
68512.0,"Janney Capital Downgrades AMAG Pharmaceuticals to Neutral, Maintains $20 PT",2018-06-15 10:35:00-04:00,AMAG,neutral
68513.0,AMAG Pharma Shares To Resume Trade At 7:30 a.m. EDT,2018-06-15 07:25:00-04:00,AMAG,positive
68514.0,AMAG Pharma Reports Divestiture Of Cord Blood Registry To GI Partners For $530M In Cash,2018-06-15 07:00:00-04:00,AMAG,neutral
68515.0,AMAG Pharma Shares Halted News Pending,2018-06-15 06:56:00-04:00,AMAG,positive
68516.0,"AMAG Pharmaceuticals Form S-3 Shows Registration For Mixed Shelf Offering, No Size Disclosed",2018-06-13 17:38:00-04:00,AMAG,negative
68517.0,"AMAG Pharma Filing Shows Registration For Mixed Securities Shelf Offering, No Amount Disclosed",2018-06-13 17:26:00-04:00,AMAG,neutral
68518.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,AMAG,neutral
68519.0,AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide,2018-06-04 07:01:00-04:00,AMAG,positive
68520.0,"Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved",2018-05-18 08:00:00-04:00,AMAG,positive
68521.0,"Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again",2018-05-11 08:21:00-04:00,AMAG,negative
68522.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,AMAG,neutral
68523.0,"Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss",2018-05-03 08:31:00-04:00,AMAG,negative
68524.0,AMAG Pharmaceuticals Raises FY2018 Sales Guidance from $500.0M-560.0M to $540.0M-580.0M vs $544.49M Est,2018-05-03 07:13:00-04:00,AMAG,neutral
68525.0,"AMAG Pharmaceuticals Q1 EPS $(1.59) Misses $(0.54) Estimate, Sales $146.356M Miss $151.79M Estimate",2018-05-03 07:12:00-04:00,AMAG,negative
68526.0,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap",2018-04-29 08:11:00-04:00,AMAG,neutral
68527.0,HC Wainwright: Why The Upside Potential For Palatin Technologies Is Nearly Fivefold,2018-04-06 14:43:00-04:00,AMAG,neutral
68528.0,Palatin Technologies Submits an NDA for Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women,2018-03-26 08:01:00-04:00,AMAG,neutral
68529.0,"AMAG Pharma 8-K Shows Co., Sandoz Entered Stipulation Of Dismissal Which Dismisses, Resolves US Patent Litigation Related To Feraheme, 30 mg/ml, 17 mL Single Dose Vials For IV",2018-03-23 08:23:00-04:00,AMAG,neutral
68530.0,"Autodesk, SCANA, And 3 Other Stocks With Clear Trading Opportunities This Week",2018-03-13 12:18:00-04:00,AMAG,positive
68531.0,"The Market In 5 Minutes: AXA Buys XL Group, Biotech Preview, Small Banks",2018-03-05 09:00:00-05:00,AMAG,neutral
68532.0,Jefferies Downgrades AMAG Pharmaceuticals to Hold,2018-03-05 08:51:00-05:00,AMAG,neutral
68533.0,"AMAG Reports Q4 EPS $0.10 vs $(0.31) In Prior Year Period, Sales $100.38M vs $97.22M In Prior Year Peirod",2018-02-27 07:10:00-05:00,AMAG,neutral
68534.0,32 Stocks Moving In Friday's Pre-Market Session,2018-02-16 08:05:00-05:00,AMAG,neutral
68535.0,46 Biggest Movers From Yesterday,2018-02-16 05:19:00-05:00,AMAG,neutral
68536.0,Mid-Afternoon Market Update: Build-A-Bear Surges On Upbeat Earnings; Inpixon Shares Drop,2018-02-15 14:28:00-05:00,AMAG,neutral
68537.0,AMAG Pharmaceutical Shares Up 29% Following FDA Approval Of Makena For At-Risk Women Preterm Birth,2018-02-15 12:36:00-05:00,AMAG,positive
68538.0,Mid-Day Market Update: SolarEdge Technologies Gains Following Q4 Earnings Beat; Avid Bioservices Shares Slide,2018-02-15 12:35:00-05:00,AMAG,positive
68539.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-02-15 12:11:00-05:00,AMAG,neutral
68540.0,Mid-Morning Market Update: Markets Open Higher; Cisco Profit Tops Estimates,2018-02-15 10:44:00-05:00,AMAG,positive
68541.0,"Benzinga's Top Upgrades, Downgrades For February 15, 2018",2018-02-15 10:24:00-05:00,AMAG,positive
68542.0,22 Stocks Moving In Thursday's Pre-Market Session,2018-02-15 08:41:00-05:00,AMAG,neutral
68543.0,Janney Capital Upgrades AMAG Pharmaceuticals Inc to Buy,2018-02-15 08:29:00-05:00,AMAG,neutral
68544.0,Benzinga Pro's 5 Stocks To Watch Today,2018-02-15 08:02:00-05:00,AMAG,neutral
68545.0,AMAG Pharma Reports FDA Approval Of Makena For At-Risk Women Preterm Birth,2018-02-14 18:03:00-05:00,AMAG,positive
68546.0,REMINDER: AMAG Pharma and Antares Pharma Have FDA PDUFA Date Today for Makena Auto-Injector sNDA,2018-02-14 07:01:00-05:00,AMAG,neutral
68547.0,"The Week Ahead: Earnings, FDA Actions, And Industry Conferences To Watch",2018-02-12 14:06:00-05:00,AMAG,neutral
68548.0,AMAG Pharma Shares Spike ~$0.55 Higher Over Last Min. Amid Report Co. Considering Sale Of Cord Blood Registry,2018-02-12 11:15:00-05:00,AMAG,positive
68549.0,AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme,2018-02-05 08:03:00-05:00,AMAG,positive
68550.0,REMINDER: AMAG Pharma Has PDUFA Date Today For Expansion of Feraheme Label to Include Iron Deficiency,2018-02-02 07:13:00-05:00,AMAG,neutral
68551.0,Attention Biotech Investors: February PDUFA Catalysts Come Calling,2018-01-31 15:30:00-05:00,AMAG,neutral
68552.0,FDA Watchlist: Catalysts To Look Out For This February,2018-01-31 11:04:00-05:00,AMAG,neutral
68553.0,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",2018-01-29 14:45:00-05:00,AMAG,negative
68554.0,"AMAG Pharma Shares Down 1.72%; Earlier Co. Reported Prelim. Q4 Adj. Sales $156M-$163M vs $161.09M Est., Operating Loss $6M-$16M, Adj. EBITDA $58M-$68M; Co. Sees FY17 Adj. Sales $613M-$620M vs $615.98M Est., FY18 Sales $500M-$560M vs $504.11M Est.",2018-01-08 11:55:00-05:00,AMAG,neutral
68555.0,AMAG Pharma Reports New Patent Entitled 'Methods Of Reducing Risk Of Preterm Birth' Issued,2017-12-20 08:04:00-05:00,AMAG,neutral
68556.0,"AMAG Pharma's Cord Blood Registry Reports 'children with cerebral palsy who received an infusion of their own neo-natal cord blood saw improved motor function and brain connectivity 1 year after treatment, when receiving a high cell dose'",2017-11-08 08:12:00-05:00,AMAG,positive
68557.0,66 Biggest Movers From Yesterday,2017-11-03 04:49:00-04:00,AMAG,neutral
68558.0,52 Stocks Moving In Thursday's Mid-Day Session,2017-11-02 12:29:00-04:00,AMAG,neutral
68559.0,"AMAG Pharmaceuticals Now Sees Wider FY17 Adj. Net Loss, From $(62M)-$(31M) to $(235M)-$(220M), Cuts Sales Outlook From $625M-$685M to $596M-$628M vs $650.1M Est.",2017-11-02 10:02:00-04:00,AMAG,negative
68560.0,"AMAG Pharmaceuticals Earlier Reported Q3 EPS $(4.31) vs $0.43 In Same Qtr. Last Year, Sales $153.7M vs $168.69M Est.",2017-11-02 10:00:00-04:00,AMAG,neutral
68561.0,"Benzinga's Top Upgrades, Downgrades For October 23, 2017",2017-10-23 09:19:00-04:00,AMAG,positive
68562.0,"PiperJaffray Initiates Coverage On AMAG Pharmaceuticals with Neutral Rating, Announces $18.00 Price Target",2017-10-23 07:21:00-04:00,AMAG,neutral
68563.0,Mid-Day Market Update: Dow Surges Over 100 Points; DURECT Shares Plummet,2017-10-20 12:01:00-04:00,AMAG,positive
68564.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,AMAG,neutral
68565.0,"AMAG Pharma Reports FDA Filing Acceptance, 6-Month Review Of Feraheme For Treatment Of All Adult Patients With Iron Deficiency Anemia",2017-08-31 08:00:00-04:00,AMAG,positive
68566.0,"AMAG Reaffirms FY17 Outlook: Sales $630M-$690M, Adj. EBITDA $210M-$260M",2017-08-03 07:24:00-04:00,AMAG,neutral
68567.0,"AMAG Pharma Reports Q2 EPS $(0.40) vs $(0.02) In Same Qtr. Last Year, Sales $158.394M vs $158.9M Est.",2017-08-03 07:24:00-04:00,AMAG,neutral
68568.0,AMAG Pharmaceuticals Launches Intrarosa In U.S.,2017-07-24 08:08:00-04:00,AMAG,neutral
68569.0,25 Stocks Moving In Monday's Pre-Market Session,2017-06-26 08:21:00-04:00,AMAG,neutral
68570.0,AMAG Pharma Supplemental new Drug Application for Makena is Accepted by the FDA,2017-06-26 08:01:00-04:00,AMAG,positive
68571.0,AMAG Reports First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study Conducted by Velo Bio,2017-06-01 08:02:00-04:00,AMAG,positive
68572.0,"Companies Holding Analyst/Investor Days Today Include DeVry Education Group, AMAG Pharma, Plains All American, & Total System Services",2017-05-24 08:53:00-04:00,AMAG,neutral
68573.0,"Seeing Notable AMAG Block Trade: 639,300 Shares At $18.10",2017-05-23 12:10:00-04:00,AMAG,negative
68574.0,AMAG Pharmaceuticals Lowers FY17 Adj. EBITDA Guidance From $270-$340 To $210-$260,2017-05-02 07:38:00-04:00,AMAG,negative
68575.0,"UPDATE: AMAG Raises FY17 Adj. Sales Outlook from $625M-$675M to $630M-$690M vs $644.2M Est., Adj. EBITDA from $270M-$340M to $210M-$260M",2017-05-02 07:10:00-04:00,AMAG,neutral
68576.0,"AMAG Pharma Raises FY17 Adj. Sales Outlook, Cuts Adj. EBITDA Guidance",2017-05-02 07:09:00-04:00,AMAG,negative
68577.0,"AMAG Pharma Reports Q1 GAAP EPS $(1.06) vs $(0.22) in Same Qtr. Last Year, Adj. EBITDA $57.6M, Sales $139.5M vs $152.4M Est.",2017-05-02 07:08:00-04:00,AMAG,neutral
68578.0,"UPDATE: AMAG Says On Track to File sNDA for Feraheme Mid-Year, Sees Potential Approval, Launch During 1H'18",2017-05-02 07:07:00-04:00,AMAG,positive
68579.0,"AMAG Pharma Offers Topline Data from Phase 3 Feraheme Label Expansion Study: Achieved All Primary, Secondary Safety, Efficacy Endpoints",2017-05-02 07:06:00-04:00,AMAG,positive
68580.0,AMAG Pharma Reports Submission of NDA for Makena Auto-Injector for Subcutaneous Use,2017-04-17 08:03:00-04:00,AMAG,neutral
68581.0,A Peek Into The Markets: U.S. Stock Futures Mostly Up Ahead Of Labor Market Conditions Index,2017-04-10 08:27:00-04:00,AMAG,neutral
68582.0,AMAG Board of Directors Approved Adoption of Shareholder Rights Plan on April 6 -8K,2017-04-10 08:06:00-04:00,AMAG,positive
68583.0,Your Cheat Sheet For Q1 Biotech Earnings,2017-04-06 12:47:00-04:00,AMAG,negative
68584.0,AMAG Pharmaceuticals Reports Closing of Exclusive Licensing Agreement With Endoceutics for U.S. Rights to Intrarosa,2017-04-04 08:01:00-04:00,AMAG,positive
68585.0,Hearing Raymond James Negative on Amag Pharma; Highlights AJOG Study Which Calls Into Question the Therapeutic Utility of HPC for Pre-Term Birth,2017-03-15 10:40:00-04:00,AMAG,negative
68586.0,AMAG Pharmaceuticals COO Frank Thomas To Leave Company,2017-03-06 08:04:00-05:00,AMAG,negative
68587.0,"AMAG, Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa; AMAG To Pay $50M Of Total Upfront Consideration And Issue Endoceutics 600K Shares Stock",2017-02-14 07:13:00-05:00,AMAG,positive
68588.0,AMAG Q4 Revenue $153.0M vs $153.3M Est,2017-02-14 07:03:00-05:00,AMAG,neutral
68589.0,"Benzinga's Top Upgrades, Downgrades For February 3, 2017",2017-02-03 09:30:00-05:00,AMAG,positive
68590.0,Cowen & Co. Downgrades AMAG Pharmaceuticals To Market Perform,2017-02-03 08:11:00-05:00,AMAG,neutral
68591.0,Palatin Tech Licenses Right to Develop Rekynda to AMAG Pharma for Initial Payment of $60M,2017-02-03 07:13:00-05:00,AMAG,neutral
68592.0,Mid-Morning Market Update: Markets Open Lower; Facebook Beats Q4 Estimates,2017-02-02 09:57:00-05:00,AMAG,negative
68593.0,"AMAG Pharmaceuticals Reports Positive Topline Results from Definitive Pharmacokinetic Study for Makena Subcutaneous Administration, On Track To Submit NDA In Q2",2017-02-02 08:02:00-05:00,AMAG,positive
68594.0,Mid-Afternoon Market Update: Ariad Pharmaceuticals Surges On Acquisition News; Stage Stores Shares Slide,2017-01-09 15:14:00-05:00,AMAG,positive
68595.0,AMAG Pharmaceuticals Tanks After Raymond James Downgrade,2017-01-09 11:45:00-05:00,AMAG,neutral
68596.0,Raymond James Downgrades AMAG Pharmaceuticals to Underperform,2017-01-09 10:26:00-05:00,AMAG,neutral
68597.0,"UPDATE: AMAG Pharmaceuticals, Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekyndatm",2017-01-09 08:28:00-05:00,AMAG,positive
68598.0,AMAG Pharmaceuticals Sees FY2017 Sales $625.0M-675.0M vs $636.0M Est,2017-01-09 08:02:00-05:00,AMAG,neutral
68599.0,"Janney Capital Initiates Coverage On AMAG Pharmaceuticals at Buy, Announces $45.00 Target",2017-01-03 16:23:00-05:00,AMAG,neutral
68600.0,Watch These 4 Huge Put Purchases In Tuesday Trade,2016-12-20 05:44:00-05:00,AMAG,positive
68601.0,Option Alert: AMAG May17 30.0 Puts: 515 @  ASK  $3.00: 1043 traded vs 5 OI:  Earnings 2/16 Before Open (est)  $35.40 Ref,2016-12-19 11:25:00-05:00,AMAG,positive
68602.0,"Cantor Fitzgerald Initiates Coverage On AMAG Pharmaceuticals at Neutral, Announces $33.00 Target",2016-12-16 08:48:00-05:00,AMAG,neutral
68603.0,Jefferies London Healthcare Conference Taking Place Today,2016-11-16 10:52:00-05:00,AMAG,neutral
68604.0,"AMAG Narrows, Raises Lower End of FY16 Outlook: Sales from $520M-$570M to $540M-$570M vs $543M Est.",2016-11-03 07:17:00-04:00,AMAG,negative
68605.0,"AMAG Pharma Reports Q3 Adj. EPS $1.81 vs $1.50 Est., Sales $145.8M vs $141.5M Est.",2016-11-03 07:16:00-04:00,AMAG,neutral
68606.0,Benzinga's Top Initiations,2016-10-27 09:35:00-04:00,AMAG,positive
68607.0,"Needham Initiates Coverage On AMAG Pharmaceuticals, Inc. - Common Stock at Buy, Announces $40.00",2016-10-27 06:19:00-04:00,AMAG,neutral
68608.0,"AMAG Pharma Reports Achievement of Key Milestones in NextGen Development Programs for Makena, Feraheme",2016-10-12 08:01:00-04:00,AMAG,neutral
68609.0,"22 Stocks Which Rallied Four Days, Then Sold Off On Friday",2016-09-19 09:49:00-04:00,AMAG,neutral
68610.0,25 Stocks Which Rallied Three Days,2016-09-16 08:04:00-04:00,AMAG,neutral
68611.0,20 Stocks Which Rallied Three Days,2016-09-15 11:05:00-04:00,AMAG,neutral
68612.0,22 Stocks Moving In Tuesday's Pre-Market Session,2016-08-09 08:48:00-04:00,AMAG,neutral
68613.0,AMAG Pharma Posts Big Q2 Beat On The Bottom Line,2016-08-09 08:10:00-04:00,AMAG,neutral
68614.0,"AMAG Sees FY16 Adj. EBITDA $255M-$285M, Sales $520M-$570M vs $533.8M Est.",2016-08-09 07:36:00-04:00,AMAG,neutral
68615.0,"AMAG Pharma Reports Q2 Adj. EPS $1.45 vs $1.20 Est., Sales $127.4M vs $1285M Est.",2016-08-09 07:36:00-04:00,AMAG,neutral
68616.0,"Worst Performing Industries For July 22, 2016",2016-07-22 11:48:00-04:00,AMAG,negative
68617.0,Raymond James Downgrades AMAG Pharmaceuticals to Market Perform,2016-05-04 07:08:00-04:00,AMAG,neutral
68618.0,"AMAG Sees FY16 Adj. EBITDA $255M-$285M, Net Income $195M-$225M",2016-05-03 07:18:00-04:00,AMAG,neutral
68619.0,"AMAG Pharma Reports Q1 Adj. EPS $0.95 vs $1.11 Est., Sales $109.3M vs $124.8M Est.",2016-05-03 07:17:00-04:00,AMAG,neutral
68620.0,AMAG Pharmaceuticals Names Edward Myles as CFO,2016-04-11 08:01:00-04:00,AMAG,neutral
68621.0,9 Stocks Moving In Today's After-Hours Session,2016-04-05 17:00:00-04:00,AMAG,neutral
68622.0,AMAG Pharmaceuticals Reports U.S. Commercical Launch For Makena,2016-04-04 08:01:00-04:00,AMAG,neutral
68623.0,"Top Performing Industries For March 31, 2016",2016-03-31 10:43:00-04:00,AMAG,positive
68624.0,Amag Pharma Announces First Patient Enrolled In Head-To-Head Phase 3 Clinical Trial Evaluating Feraheme In Adults W/ Iron Deficiency Amenia,2016-03-16 07:02:00-04:00,AMAG,neutral
68625.0,"Index Shuffling: Snyder's-Lance Will Replace California Resources In S&P MidCap 400, AMAG Pharma To Replace Diamond Foods In SmallCap 600",2016-02-24 08:07:00-05:00,AMAG,positive
68626.0,"S&P Announces Snyder's-Lance to Replace California Resources in S&P MidCap 400, Trex Will Replace Snyder's, AMAG Pharma Will Replace Diamond Foods in SmallCap 600",2016-02-23 17:31:00-05:00,AMAG,positive
68627.0,"AMAG Pharmaceuticals Announces FDA Approval of New Single-Dose, Preservative-Free Makena",2016-02-23 12:47:00-05:00,AMAG,positive
68628.0,"Earnings Scheduled For February 17, 2016",2016-02-17 04:08:00-05:00,AMAG,neutral
68629.0,"8-K from AMAG Pharma Shows Co. Received Paragraph IV Certification Related to ANDA Submitted to FDA by Sandoz Requesting Approval to Engage in Commercial Manufacture, Use, Sale of Ferumoxytol",2016-02-08 17:09:00-05:00,AMAG,positive
68630.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,AMAG,positive
68631.0,"Barclays Initiates Coverage on AMAG Pharmaceuticals at Equal-weight, Announces $32.00 PT",2016-01-21 05:23:00-05:00,AMAG,neutral
68632.0,13G Filing Shows Amag Pharma Holder DE SHaw & Co LP Holds 5.0% Stake As of Jan 4,2016-01-14 16:04:00-05:00,AMAG,neutral
68633.0,Benzinga's Volume Movers,2016-01-11 10:33:00-05:00,AMAG,neutral
68634.0,"AMAG Pharmaceuticals Sees Q4 Rev. $116-$124M vs. Est. $123.08M, FY15 Rev. $431-$441M vs. Est. $412.74M",2016-01-11 08:09:00-05:00,AMAG,neutral
68635.0,Jefferies' Best Biotech Ideas For 2016 (And Beyond),2016-01-06 15:52:00-05:00,AMAG,positive
68636.0,"AMAG Shares Trading Up 1.5% After The Company Announced A Buyback Of $60M This Morning, Company Notes That There Is No Time Limit And Can Be Discontinued At Anytime",2016-01-06 12:10:00-05:00,AMAG,neutral
68637.0,AMAG Pharma Names Nicholas Grund as Chief Commercial Officer,2016-01-04 08:04:00-05:00,AMAG,neutral
68638.0,"Jefferies Maintains Buy Rating, $70 Target on AMAG Pharma; Cuts FY16-FY18 Adj. EPS Estimates by ~12-16% Amid Changes to Accounting Treatment for Makena-Related Payments, Updated Diluted Share Counts",2015-12-28 11:09:00-05:00,AMAG,neutral
68639.0,AMAG Shares Spiking,2015-12-16 15:33:00-05:00,AMAG,positive
68640.0,"AMAG Pharmaceuticals Responds to Recent Complete Response Letter From the FDA for the Single-Dose, Preservative-Free Vial of Makena(R)",2015-11-23 08:02:00-05:00,AMAG,neutral
68641.0,Mid-Afternoon Market Update: Kirkland's Drops On Downbeat Earnings; Perry Ellis Shares Spike Higher,2015-11-19 15:03:00-05:00,AMAG,positive
68642.0,Stocks Hitting 52-Week Lows,2015-11-19 10:24:00-05:00,AMAG,negative
68643.0,Morning Market Losers,2015-11-19 09:52:00-05:00,AMAG,negative
68644.0,Benzinga's Top #PreMarket Losers,2015-11-19 08:25:00-05:00,AMAG,negative
68645.0,UPDATE: AMAG Says Remains '...committed to working with the FDA to bring this product to market.',2015-11-18 17:46:00-05:00,AMAG,neutral
68646.0,AMAG Pharma Reports Received CRL from FDA Related to Single-Dose Vial of Makena,2015-11-18 17:44:00-05:00,AMAG,neutral
68647.0,Mid-Afternoon Market Update: Dow Rises 125 Points; RetailMeNot Shares Climb On Earnings Beat,2015-11-03 15:13:00-05:00,AMAG,positive
68648.0,Mid-Day Market Update: US Stocks Rise; TASER Shares Drop On Downbeat Earnings,2015-11-03 12:44:00-05:00,AMAG,neutral
68649.0,"Worst Performing Industries For November 3, 2015",2015-11-03 11:29:00-05:00,AMAG,negative
68650.0,Mid-Morning Market Update: Markets Edge Lower; Activision Blizzard To Acquire King Digital For $5.9B,2015-11-03 10:03:00-05:00,AMAG,negative
68651.0,Morning Market Losers,2015-11-03 09:51:00-05:00,AMAG,negative
68652.0,"AMAG Pharmaceuticals Reports Q3 ESP $1.02 vs. Est. $1.21, Rev. $103.5M vs. Est. $113.88M",2015-11-03 07:31:00-05:00,AMAG,neutral
68653.0,AMAG Pharmaceuticals Announces Head-to-Head Phase 3 Clinical Trial Evaluating Feraheme(R) in Adults With Iron Deficiency Anemia,2015-10-28 07:13:00-04:00,AMAG,neutral
68654.0,"Amag Pharma Spiking To HOD, Currently At $39.10",2015-10-23 14:50:00-04:00,AMAG,neutral
68655.0,"Hearing Raymond James Reiterates Outperform, $75 PT On Amag Pharma",2015-09-24 15:15:00-04:00,AMAG,neutral
68656.0,Amag Pharma Spikes to High,2015-09-24 15:13:00-04:00,AMAG,neutral
68657.0,AMAG Pharma Has Catalysts Coming; Stock Could Rise $30,2015-09-18 10:31:00-04:00,AMAG,neutral
68658.0,"Worst Performing Industries For September 11, 2015",2015-09-11 11:52:00-04:00,AMAG,negative
68659.0,AMAG Pharmaceuticals Appoints Joseph Vittiglio as General Counsel and Secretary,2015-08-24 16:00:00-04:00,AMAG,neutral
68660.0,Why Biotech AMAG Pharma Is Worth $80 Now,2015-08-18 10:23:00-04:00,AMAG,positive
68661.0,"Jefferies Assumes AMAG Pharmaceuticals at Buy, Announces $80.00 PT",2015-08-18 08:16:00-04:00,AMAG,neutral
68662.0,AMAG Pharmaceuticals Prices 3.15M Share Offering @$63.75/Share,2015-07-30 20:23:00-04:00,AMAG,positive
68663.0,"AMAG Pharma Reports Q2 Adj EPS $1.12 Vs Est $1.13, Sales $123.9M Vs Est $94.05M, Sees 2015 Rev $395M-$430M",2015-07-23 07:13:00-04:00,AMAG,neutral
68664.0,"Benzinga's M&A Chatter for Monday June 29, 2015",2015-06-29 19:43:00-04:00,AMAG,neutral
68665.0,AMAG Pharmaceuticals Acquires Cord Blood Registry From GTCR For $700M,2015-06-29 07:26:00-04:00,AMAG,neutral
68666.0,Amag Pharma Announces Acquisition of Cord Blood Registry For $700M,2015-06-29 07:01:00-04:00,AMAG,neutral
68667.0,Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin,2015-06-23 05:01:00-04:00,AMAG,positive
68668.0,"Top Performing Industries For June 18, 2015",2015-06-18 10:30:00-04:00,AMAG,positive
68669.0,Benzinga's Top Initiations,2015-06-12 09:19:00-04:00,AMAG,positive
68670.0,Deutsche Bank Initiates AMAG Pharmaceuticals With Hold,2015-06-12 08:21:00-04:00,AMAG,neutral
68671.0,"Deutsche Bank Initiates Coverage on AMAG Pharmaceuticals at Hold, Announces $75.00 PT",2015-06-12 07:38:00-04:00,AMAG,neutral
68672.0,5 NASDAQ Healthcare Stocks With The Highest Profit Margin,2015-06-10 09:21:00-04:00,AMAG,positive
68673.0,AMAG Pharmaceuticals Appoints Aaron Pelta as Vice President of Business Development,2015-06-09 16:31:00-04:00,AMAG,neutral
68674.0,"AMAG Pharmaceuticals Names Julie Krop, M.D. as New Chief Medical Officer",2015-06-02 08:35:00-04:00,AMAG,neutral
68675.0,UPDATE: AMAG Pharma Reaffirms FY15 Sales Guidance in $395M-$430M Range,2015-05-28 08:15:00-04:00,AMAG,neutral
68676.0,AMAG Pharma Announces Received CRL from FDA Related to Single-Dose Vial of Makena(R),2015-05-28 08:01:00-04:00,AMAG,neutral
68677.0,AMAG Pharmaceuticals Expands Resources Dedicated to Reducing the Risk of Preterm Birth,2015-05-20 08:02:00-04:00,AMAG,positive
